Valuation: Cellnovo

Market Cap 24.36L 21.64L 20.2L 18.41L 34.72L 23Cr 35.04L 2.44Cr 94.72L 12Cr 91.45L 89.46L 38Cr P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 1.25Cr 1.11Cr 1.03Cr 94.16L 1.78Cr 119.76Cr 1.79Cr 13Cr 4.84Cr 61Cr 4.68Cr 4.58Cr 196.49Cr EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.79L
+1.65%+3.29%-0.49%+64.70% 3,84300Cr
-0.29%+0.39%+4.84%+1,090.48% 45TCr
+0.99%+8.87%-50.49%+33.23% 43TCr
+0.17%+2.91%+89.82%+240.83% 33TCr
+0.41%+4.62%+118.76%+556.37% 28TCr
+0.89%+1.24%-19.56%+52.53% 24TCr
+0.86%+3.63%-25.39%+24.47% 14TCr
+0.68%+3.32%+110.91%+214.00% 13TCr
+0.19%+3.46%+76.67%+210.48% 9.95TCr
Average +0.54%+2.40%+33.90%+276.35% 59.45TCr
Weighted average by Cap. +1.19%+1.25%+9.29%+177.72%

Financials

2018 2019 *
Net sales 33.22L 29.51L 27.55L 25.11L 47.35L 32Cr 47.79L 3.33Cr 1.29Cr 16Cr 1.25Cr 1.22Cr 52Cr -
Net income -1.59Cr -1.42Cr -1.32Cr -1.2Cr -2.27Cr -153.23Cr -2.29Cr -16Cr -6.2Cr -78Cr -5.98Cr -5.85Cr -251.39Cr -
Net Debt 1Cr 89.05L 83.11L 75.75L 1.43Cr 96Cr 1.44Cr 10Cr 3.9Cr 49Cr 3.76Cr 3.68Cr 158.07Cr -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock